Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease.
Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease.
复制标题
Interleukin-22 可能是治疗 2 型糖尿病和冠状动脉疾病的双刃剑
DOI:
10.1155/2016/8254797
复制
发表时间:
2016
影响因子:
4.6
通讯作者:
Liu Z
中科院分区:
文献类型:
--
作者:
Gong F;Wu J;Zhou P;Zhang M;Liu J;Liu Y;Lu X;Liu Z
Type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are both characterized by chronic low-grade inflammation. The role of Th17 and its related cytokines in T2DM and CAD is unclear. Here we investigated the serum levels of five Th17-related cytokines (IL-17, IL-22, MIP-3α, IL-9, and IL-27) in T2DM, CAD, and T2DM-CAD comorbidity patients. IL-22 was found to be elevated in all three conditions. Elevated serum IL-22 was independently associated with the incidence of T2DM and CAD. Conversely, IL-22 was found to protect endothelial cells from glucose- and lysophosphatidylcholine- (LPC-) induced injury, and IL-22R1 expression on endothelial cells was increased upon treatment with high glucose and LPC. Blocking of IL-22R1 with IL-22R1 antibody diminished the protective role of IL-22. Our results suggest that IL-22 functions as a double-edged sword in T2DM and CAD and that IL-22 may be used in the treatment of chronic inflammatory diseases such as T2DM and CAD.
登录
查看更多内容
DOI:
10.4049/jimmunol.1302246
发表时间:
2015-11-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Peters A;Fowler KD;Chalmin F;Merkler D;Kuchroo VK;Pot C
通讯作者:
Pot C
影响因子:
4.4
作者:
Pastore, S;Mascia, F;Girolomoni, G
通讯作者:
Girolomoni, G
影响因子:
5.2
作者:
Frostegård J
通讯作者:
Frostegård J
影响因子:
39.3
作者:
Paneni F;Beckman JA;Creager MA;Cosentino F
通讯作者:
Cosentino F
影响因子:
7.7
作者:
Dalmas, Elise;Venteclef, Nicolas;Guerre-Millo, Michele
通讯作者:
Guerre-Millo, Michele